COCRYSTAL PHARMA, INC. Disposal Group, Including Discontinued Operation, General and Administrative Expense
COCRYSTAL PHARMA, INC. (COCP) reported Disposal Group, Including Discontinued Operation, General and Administrative Expense of $9.77 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense · last filed 2014-03-31
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2013-12-31 was $9.72M, a 56.07% increase year-over-year.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2013-09-30 was $4.00K, a 80.39% decline year-over-year.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2012-12-31 was $6.23M.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, general and administrative expense for the quarter ending 2012-09-30 was $20.40K.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2013 was $9.77M, a 55.60% increase from fiscal 2012.
- COCRYSTAL PHARMA, INC. disposal group, including discontinued operation, general and administrative expense for fiscal 2012 was $6.28M.
| Period end | Disposal Group, Including Discontinued Operation, General and Administrative Expense 3 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 6 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 9 month | Disposal Group, Including Discontinued Operation, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2013-12-31 | $9.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $9.72M derived: sum of 2 quarters · filed 2014-03-31 | $9.77M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $4.00K 10-Q · filed 2013-11-18 | $45.81K 10-Q · filed 2013-11-18 | ||
| 2012-12-31 | $6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $6.25M derived: sum of 2 quarters · filed 2014-03-31 | $6.28M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $20.40K 10-Q · filed 2013-11-18 | $48.27K 10-Q · filed 2013-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |